Patents Examined by Lester L. Lee
  • Patent number: 5023236
    Abstract: The invention includes a class of compounds that inhibit the specific proteolytic activity of the bimolecular complex 1[TF:VII/VIIa] that initiates the blood coagulation systems. Both reversible and irreversible inhibitors are disclosed.The invention encompasses the use of inhibitors of the active site of the factor VII and VIIa component of [TF:VII/VIIa] as diagnostic reagents, as analytical reagents, and as therapeutic drugs.The invention includes the compounds based on the following general formula for both reversible and irreversible selective inhibition of [TF:VII/VIIa].
    Type: Grant
    Filed: March 13, 1989
    Date of Patent: June 11, 1991
    Assignee: Corvas, Inc.
    Inventors: T. Scott Edgington, Michael G. Pepe
  • Patent number: 5021549
    Abstract: New physiologically active substances, named probestin and prostatin, respectively, are produced from a new microorganism, Streptomyces azureus MH663-2F6 strain identified as FERM P-9541 or FERM BP-1963. Probestin and prostatin have an activity inhibitory to aminopeptidase M and also have immunopotentiating properties.
    Type: Grant
    Filed: August 16, 1988
    Date of Patent: June 4, 1991
    Assignee: Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai
    Inventors: Tomio Takeuchi, Takaaki Aoyagi, Masa Hamada, Hiroshi Naganawa, Shigemi Yoshida
  • Patent number: 5019601
    Abstract: A novel elastomeric composition of matter comprises a rubber latex and a masterbatch comprising a therapeutic agent in a therapeutically effective amount, a carrier component, titanium dioxide, and clay. A process for the preparation of a novel elastomeric composition of matter containing a therapeutic agent includes the steps of preparaing a masterbatch containing a therapeutic agent, adding the masterbatch to a rubber latex and thereafter forming and curing a desired product therefrom. The composition is useful in the manufacture of rubber goods such as surgical and medical products which can be single or multilayered.
    Type: Grant
    Filed: August 18, 1989
    Date of Patent: May 28, 1991
    Assignee: Cuno, Incorporated
    Inventor: Dwight L. Allen
  • Patent number: 5019378
    Abstract: A novel elastomeric composition of matter comprises a rubber latex and a masterbatch comprising a therapeutic agent in a therapeutically effective amount, a carrier component, titanium dioxide, and clay. A process for the preparation of a novel elastomeric composition of matter containing a therapeutic agent includes the steps of preparing a masterbatch containing a therapeutic agent, adding the masterbatch to a rubber latex and thereafter forming and curing a desired product therefrom. The composition is useful in the manufacture of rubber goods such as surgical and medical products which can be single or multilayered.
    Type: Grant
    Filed: August 18, 1989
    Date of Patent: May 28, 1991
    Assignee: Cuno, Incorporated
    Inventor: Dwight L. Allen
  • Patent number: 5019383
    Abstract: A synthetic vaccine is contemplated comprising a peptide residue coupled to one or more alkyl or alkenyl groups of at least 12 carbon atoms or other lipophilic substance wherein said peptide residue contains a sequence of 6 amino acids corresponding to the sequence of such amino acids in a protein antigen or allergen where the greatest local average hydrophilicity of the antigen or allergen is found.
    Type: Grant
    Filed: September 8, 1989
    Date of Patent: May 28, 1991
    Assignee: New York Blood Center, Inc.
    Inventor: Thomas P. Hopp
  • Patent number: 5017689
    Abstract: Cyclic disulfide and linear dynorphin Dyn A.sub.1-11 and dynorphin Dyn A.sub.1-13 analogs which are highly specific for .kappa. opioid receptors. These analogs are useful in pharmaceutical compositions and for the analysis of opioid receptor/ligand interactions.
    Type: Grant
    Filed: July 6, 1989
    Date of Patent: May 21, 1991
    Assignee: Arizona Technology Development Corporation
    Inventors: Victor Hruby, Andrew Kawasaki
  • Patent number: 5017377
    Abstract: A controlled release insect pest repellent comprising p-menthane-3,8-diol blended with an ethylene/vinyl acetate copolymer is disclosed. This controlled release insect pest repellent can show continuous controlled release of the repellent component, i.e., p-menthane-3,8-diol, for a prolonged period of time so as to effectively exterminate insect pests.
    Type: Grant
    Filed: October 31, 1989
    Date of Patent: May 21, 1991
    Assignee: Takiran Co., Ltd.
    Inventors: Yasuo Sikinami, Kunihiro Hata, Masaki Yasuhara
  • Patent number: 5015633
    Abstract: A method is provided for inhibiting loss of cognitive function, including memory, which may or may not be associated with Alzhemier's disease, in a mammalian species by administering an ACE inhibitor, which is a phosphonate substituted amino or imino acid or salt, such as SQ 29,852 over a prolonged period of treatment.
    Type: Grant
    Filed: February 9, 1989
    Date of Patent: May 14, 1991
    Assignee: E. R. Squibb & Sons, Inc.
    Inventor: Abraham Sudilovsky
  • Patent number: 5015627
    Abstract: A stabilized somatotropin peptide aldehyde complex which provides prolonged release of the somatotropin and enhanced feed efficiency. The complex is prepared by dissolving the somatotropin and peptide aldehyde in water, isolating the complex from the aqueous solution, and crystalizing the product from alcohol. Specifically, the complex comprises porcine somatotropin and leupeptin and is particularly useful for enhancing feed efficiency in swine.
    Type: Grant
    Filed: July 20, 1990
    Date of Patent: May 14, 1991
    Assignee: SmithKline Beecham Corporation
    Inventors: Thomas O. Lindsey, Michael T. Clark
  • Patent number: 5015626
    Abstract: Muscle quality of pigs normally susceptible to porcine stress syndrome is improved by administering to the pigs in conjunction with their daily feed ration, a small amount of porcine somatotropin.
    Type: Grant
    Filed: August 2, 1989
    Date of Patent: May 14, 1991
    Assignee: Iowa State University Research Foundation, Inc.
    Inventors: Lauren L. Christian, Lindy F. Miller
  • Patent number: 5013306
    Abstract: An anti-infective medical article has chlorhexidine bulk distributed throughout a polyurethane base layer and may have a coating layer on the base layer. The coating layer may be chlorhexidine permeated into the surface or it may be an antibiotic, antithrombogenic agent or a polymeric surface layer laminated onto the base layer. The invention includes a method for preparing the article wherein a homogeneous melt of polymer and chlorhexidine is prepared by twin screw compounding and the melt is extruded to give a medical article having bulk distributed chlorhexidine.
    Type: Grant
    Filed: March 21, 1990
    Date of Patent: May 7, 1991
    Assignee: Becton, Dickinson and Company
    Inventors: Donald D. Solomon, M. Parke Byron
  • Patent number: 5013552
    Abstract: Loaded pollen grains are disclosed which are suitable for use as delivery systems for introducing biologically active substances into or on plants and animals. Such pollen grains are suitable to deliver both small and large (macromolecules) molecules. Preferred pollen grains are those that have been defatted and then pre-treated to be free of antigenic materials and that have special surface features that facilitate their attachment to tissue surfaces, particularly to mucous membranes. The most preferred pollen grains are those that have spiny or irregular or fragmented surfaces. Also disclosed are a method of pre-treating the pollen grains to remove antigenic materials; a method of loading the pollen grains with the biologically active material; and a method of incorporating such pre-treated, loaded pollen grains into formulations or dosage forms suitable for introduction into or on a plant or animal body.
    Type: Grant
    Filed: February 6, 1989
    Date of Patent: May 7, 1991
    Inventors: Moh. Samir Amer, Rashad Tawashi
  • Patent number: 5013544
    Abstract: Pharmaceutical compositions comprising a combination of a polymeric biguanide and a spermicidal surfactant, useful for contraceptive purposes, for their spermicidal or sperm-immobilizing effect, and contraceptive methods and devices using them.The polymeric biguanide is preferably a compound as described in U.K. Patent Specification No. 702,268 or a bisbiguanide as described in U.K. Patent Specification No. 705,838 or 1,095,902, but especially chlorhexidine. The spermicidal surfactant may be derived from ethylene oxide, preferably a condensate of nonylphenol and ethylene oxide, and especially with 9 to 11 molecular proportions thereof.To avoid short-lived activity, the compositions are preferably made substantially free from anions (notably halide ions and especially chloride ions) which cause deactivation, apparently by reducing the solubility of the active ingredients.
    Type: Grant
    Filed: January 29, 1990
    Date of Patent: May 7, 1991
    Assignee: The Victoria University of Manchester
    Inventors: Eric N. Chantler, Max Elstein
  • Patent number: 5011825
    Abstract: The invention relates to peptides of the formulaR.sup.N --L--N--B.sup.2 --R.sup.C (I)in which R.sup.N denotes an acyl radical, L denotes a radical of a lipophilic, neutral .alpha.-amino acid, N denotes a radical of an neutral .alpha.-amino acid, B.sup.2 denotes the radical of a basic .alpha.-amino acid, and R.sup.C denotes an amido radical; a process for their preparation, agents containing these peptides, and their use.
    Type: Grant
    Filed: January 8, 1990
    Date of Patent: April 30, 1991
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Wolfgang Konig, Gerhard Breipohl, Rolf Geiger, Jochen Knolle, Max Hropot
  • Patent number: 5011910
    Abstract: Novel fluorogenic substrates for retroviral protease, e.g. HIV protease, having the chemical structure X--Thr--Ile--Nle--Phe(Y)--Gln--Arg--NH.sub.2 wherein X is a fluorogenic group and Y is an acceptor for the fluorogenic group, and their use in a fluorometric method for the determination of retroviral protease is disclosed.
    Type: Grant
    Filed: December 28, 1989
    Date of Patent: April 30, 1991
    Assignee: Washington University
    Inventors: Garland R. Marshall, Mihaly V. Toth
  • Patent number: 5010057
    Abstract: Renin-inhibiting aminomethyl peptides of the formula ##STR1## in which A is H, an alkyl radical, a sulphonyl radical or an amino-protecting group,B, D, E and F each independently is a direct bond or an amino-organo-carbonyl group,R.sup.1 is an optionally substituted alkyl or aryl radical,R.sup.2 is H, alkyl or acyl,R.sup.3 is H, alkyl, aryl or acyl, andR.sup.4 is alkyl, alkoxy, aryl or amino,and physiologically acceptable salts thereof.
    Type: Grant
    Filed: August 17, 1989
    Date of Patent: April 23, 1991
    Assignee: Bayer Aktiengesellschaft
    Inventors: Rolf Henning, Gunter Benz, Johannes-Peter Stasch, Andreas Knorr, Wolfgang Bender
  • Patent number: 5010174
    Abstract: There is disclosed a calcitonin derivative and its salt, comprising an amino acid residue at the 1-position of calcitonin which is a cyclic amino acid residue represented by the formula: ##STR1## wherein X represents a sulfur atom or a methylene group; and n represents an integer of 0 or 1. and an amino acid residue at the 7-position which is a cysteine residue which may be substituted with an appropriate protective group.
    Type: Grant
    Filed: May 17, 1989
    Date of Patent: April 23, 1991
    Assignee: Mitsubishi Petrochemical Co., Ltd.
    Inventors: Sachio Hirose, Motomu Hane, Masanobu Inagawa
  • Patent number: 5010008
    Abstract: A process for preparing a stable liquid enzyme concentrate containing the alpha-amylase from Bacillus stearothermophilus. A commercial alpha-amylase enzyme preparation is treated with granular starch to absorb the enzyme, and the starch containing the enzyme is separated and then heated in a buffer solution containing calcium ion. The resulting solution, separated from insoluble solid, is then concentrated to give the final product.
    Type: Grant
    Filed: December 12, 1988
    Date of Patent: April 23, 1991
    Assignee: Enzyme Bio-Systems Ltd.
    Inventor: Phillip J. Brumm
  • Patent number: 5008244
    Abstract: Somatotropin is administered to food producing animals in the finishing stage of growth to increase fertility by increasing embryonic survival and litter size during the reproductive stage of growth.
    Type: Grant
    Filed: May 15, 1989
    Date of Patent: April 16, 1991
    Assignee: Pitman-Moore, Inc.
    Inventors: Lindy F. Miller, Peter J. Thomford
  • Patent number: 5008246
    Abstract: The invention relates to novel peptides and their acid addition salts, suppressing the function of the immune system, pharmaceutical compositions containing these peptides as well as to a process for preparing these peptides and compositions. The peptides are represented by formulae (1) to (16): ##STR1## The novel peptides are useful for the therapy of diseases where a decrease in the activity of the immune system is desirable.
    Type: Grant
    Filed: June 13, 1989
    Date of Patent: April 16, 1991
    Assignee: Richter Gedeon Vegyeszeti Gyar R. T.
    Inventors: Istvan Schon, Olga Nyeki, Lajos Kisfaludy, deceased, Laszlo Denes, Gyorgy Hajos, Laszlo Szporny